— Know what they know.
Not Investment Advice

PODD NASDAQ

Insulet Corporation
1W: +5.5% 1M: -19.0% 3M: -35.2% YTD: -44.6% 1Y: -52.1% 3Y: -51.0% 5Y: -32.5%
$154.87
-2.02 (-1.29%)
 
Weekly Expected Move ±10.3%
$117 $132 $147 $163 $178
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Sell · Power 41 · $10.7B mcap · 69M float · 2.03% daily turnover · Short 32% of daily vol

Cash Flow Trends

Operating Cash Flow
$569M +32.3% ▲
5Y CAGR: +46.6%
Capital Expenditures
$192M -53.4% ▼
5Y CAGR: +2.8%
Free Cash Flow
$378M +23.7% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$60M +0.0% ▲
Net Change in Cash
-$237M -195.2% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$17M$5M$206M$418M$247M
Depreciation & Amort.$57M$63M$73M$81M$90M
Stock-Based Comp.$34M$41M$48M$69M$63M
Change in Working Capital-$264M-$2M-$191M-$17M-$23M
Other Non-Cash Items$87M$14M$8M$16M$130M
Operating Cash Flow-$68M$119M$146M$430M$569M
— Investing Activities —
Capital Expenditures-$123M-$157M-$109M-$134M-$192M
Acquisitions (Net)$0-$26M-$3M$0$0
Investment Purchases$0-$8M-$7M-$12M$0
Investment Sales$40M$0$0$0$0
Other Investing$0$0$0$0-$31M
Investing Cash Flow-$83M-$191M-$119M-$146M-$223M
— Financing Activities —
Net Debt Issuance$49M-$40M-$27M-$41M-$708M
Stock Repurchased$0$0$0$0-$60M
Dividends Paid$0$0$0$0$0
Other Financing-$32M-$17M-$14M-$8M$138M
Financing Cash Flow$41M-$40M-$14M-$28M-$595M
Net Change in Cash-$116M-$117M$14M$249M-$237M
Cash End of Period$806M$690M$704M$953M$716M
Free Cash Flow-$191M-$38M$70M$305M$378M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms